In gastric cancer, METTL3 promoted the m6A modification of HDGF mRNA, and the m6A reader IGF2BP3 directly recognized and bound to the m6A site on HDGF mRNA and enhanced HDGF mRNA stability [40]. Here, METTL3 is linked to gastric cancer.